Entellus, a Covidien-backed developer of devices to treat sinustisis, has raised $92m in funding since it was formed.

First Analysis provided the funding for the Ascension Health and Legacy Life Science-backed orthopaedic device maker as it prepares to release its next product.

Merck and Johnson & Johnson have provided backing for the Atlas Venture-incubated company, which is developing treatments for autoimmune diseases.

Google-backed healthcare IT company Predilytics has now raised $20.5m after doubling its customer base over 2014.

Qiagen has joined the investors in diagnostic testing company Protagen, the month after the two signed a collaboration agreement.

Cancer drug developer Flexus has closed a Celgene-backed series B round that boosted its overall funding to $38m.

Novartis has taken a 12.8% stake in pharmaceutical company BiolineRx as part of a partnership agreement.

US-based accelerator Techstars is set to launch programmes in affiliation with Ford, Verizon, Magna and Mayo Clinic.

The GE Healthcare-backed ultrasound system developer has now raised more than $130m, and investors have another month to commit a further $3.5m.